Genomics • Diagnostics • Bioinformatics • Rare Diseases • Precision Medicine
Former leadership roles at QIAGEN and SOPHiA GENETICS
Transforming genomic innovation into clinical impact.
Product and strategy leader at the intersection of genomics, diagnostics, AI, and precision medicine. Proven track record of driving innovation, scaling global product portfolios, and translating scientific complexity into clinically actionable solutions that create measurable value for patients, providers, and healthcare organizations.
Commercially minded genomics platform geneticist, product and AI strategy leader with 15+ years of experience driving innovation, product strategy, commercialization and enterprise adoption across molecular diagnostics, clinical genomics software and precision medicine.
Proven track record leading global product teams, shaping platform roadmaps and delivering integrated diagnostics solutions combining NGS assays, bioinformatics, AI-enabled interpretation and clinical decision support technologies.
Passionate about translating complex genomics challenges into scalable, clinically actionable solutions that improve patient outcomes and drive business growth.
Leadership roles at QIAGEN and SOPHiA GENETICS, driving global product strategy, portfolio growth and innovation.
Delivered >35% annual portfolio growth and scaled Rare Disease & Precision Medicine solutions >10x in two years due to key differentiator features and products.
Led development of integrated NGS, software, AI interpretation and clinical decision support solutions.
Directed and closely collaborated with Product, Science, Engineering, Regulatory and Commercial teams across global organizations.
Collaborated with Natera, Labcorp, NeoGenomics and leading healthcare institutions worldwide.
Delivered genomic variant reinterpretation, evidence monitoring and AI-enabled clinical solutions.
Lead global product strategy, commercial portfolio growth, AI initiatives and precision medicine solutions commercialization and adoption.
Drove conception and development of clinical genomics applications, and integrated software solutions with strong market growth and clinical impact. Drove market expansion footprint in Rare diseases through spearhead products.
Human genetics research, genomics innovation and translational medicine, and NGS diagnostics.
Genomics research and molecular biology projects related to methylation of lung cancer.
Research in human genetics and ovarian cancer.
Human-Medical Genetics
University of Geneva
Medical Genetics
University of Glasgow
University of Pennsylvania
Molecular Biology & Genetics
Democritus University of Thrace
First Author publication in Nature communication journal and multiple publications in international high impact factor journals.
International presentations and invited talks in ESHG, ASHG, HUGO, AMP.
ACMG • ASHG • ESHG • AMP • HUGO
